Evidence map›Paper›PMID 35199944›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2022

Hypertension continuum of care: Blood pressure screening, diagnosis, treatment, and control in a population-based cohort in Haiti.

Miranda Metz, Jean Lookens Pierre, Lily Du Yan, Vanessa Rouzier, Stephano St-Preux, Serfine Exantus, Fabyola Preval, Nicholas Roberts, Olga Tymejczyk, Rodolphe Malebranche and 3 more

Registry-linked trialAbstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03892265 (A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti), which is not on this map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03892265 active not recruitingnot on this map

A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti

TypeobservationalSponsorWeill Medical College of Cornell UniversityRan2019 to 2028Enrolled3,005ConditionsHypertension, Diabetes, Obesity, Kidney DiseasesArmsObservational Study
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Miranda MetzCenter for Global Health, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.ORCID 0000-0003-1719-3569
Jean Lookens PierreGHESKIO, Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections, Port-au-Prince, Haiti.
Lily Du YanCenter for Global Health, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Vanessa RouzierGHESKIO, Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections, Port-au-Prince, Haiti.
Stephano St-PreuxGHESKIO, Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections, Port-au-Prince, Haiti.
Serfine ExantusGHESKIO, Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections, Port-au-Prince, Haiti.
Fabyola PrevalGHESKIO, Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections, Port-au-Prince, Haiti.
Nicholas RobertsCenter for Global Health, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Olga TymejczykCity University of New York Institute for Implementation Science in Population Health, New York, New York, USA.
Rodolphe MalebrancheCollège Haïtien de Cardiologie, Port-au-Prince, Haiti.
Marie Marcelle DeschampsGHESKIO, Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections, Port-au-Prince, Haiti.
Jean W PapeGHESKIO, Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections, Port-au-Prince, Haiti.
Margaret L McNairyCenter for Global Health, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.

Funding

Disparities in COVID Disease Severity and Outcomes in New York CityUL1TR002384 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JULIANNE L IMPERATO-MCGINLEY · 2017 to 2026
$86.2M
GHESKIO HIV Clinical Trial UnitUM1AI069421 · NIAID · GHESKIO CENTER · PI JEAN WILLIAM PAPE · 2012 to 2026
$23.6M
Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep DisordersR01HL143788 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI Margaret Leighton McNairy · 2018 to 2026
$8.9M
Cardiovascular Disease Research Training Program in HaitiD43TW011972 · FIC · WEILL MEDICAL COLL OF CORNELL UNIV · PI Margaret Leighton McNairy, JEAN WILLIAM PAPE · 2021 to 2026
$1.4M
Global Health Research and Training in Cardiovascular DiseaseK24HL163393 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI Margaret Leighton McNairy · 2022 to 2026
$604k
FIC NIH HHS D43 TW011972NCATS NIH HHS UL1 TR002384NHLBI NIH HHS K24 HL163393NHLBI NIH HHS R01 HL143788NIAID NIH HHS UM1 AI069421
6 · The paper itself

Abstract

Cardiovascular disease (CVD) is the number one cause of death in low-income countries including Haiti, with hypertension (HTN) being the leading risk factor. This study aims to identify gaps in the HTN continuum of screening, diagnosis, treatment, and blood pressure (BP) control. Sociodemographic and clinical data were collected from a population-based sample of adults ≥18 years in Port-au-Prince (PAP) from March 2019 to April 2021. HTN was defined as systolic BP ≥ 140 mmHg, diastolic BP ≥ 90 mmHg, or use of antihypertensive medication. Screening was defined as ever having had a BP measurement; diagnosis as previously being informed of a HTN diagnosis; treatment as having taken antihypertensives in the past 2 weeks; and controlled as taking antihypertensives and having BP < 140/90 mmHg. Factors associated with attaining each step in the continuum were assessed using Poisson multivariable regressions. Among 2737 participants, 810 (29% age-standardized) had HTN, of whom 97% had been screened, 72% diagnosed, 45% treated, and 13% controlled. There were no significant differences across age groups or sex. Obesity (BMI ≥ 30) was a significant factor associated with receiving treatment compared to normal weight (BMI < 25), with a prevalence ratio (PR) of 1.5 (95% CI 1.1-2.0). Having secondary or higher education was associated with higher likelihood of controlled BP (PR 1.9 [95% CI 1.1-3.3]). In this urban Haitian population, the greatest gaps in HTN care are treatment and control. Targeted interventions are needed to improve these steps, including broader access to affordable treatment, timely distribution of medications, and patient adherence to HTN medication.

Indexed as

HypertensionAdultAntihypertensive AgentsBlood PressureContinuity of Patient CareHaitiHumansAntihypertensive Agentscardiovascular diseasecontinuum of careHaitihypertension

Identifiers

PMID35199944
PMCPMC8925011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.